期刊文献+

AFP阳性、超声与MSCT阴性人群中应用DSA检出早期肝癌的研究 被引量:2

Detection of early hepatocellular carcinoma by DSA in AFP-positive,ultrasound and/or MSCT-negative population
暂未订购
导出
摘要 目的:探讨AFP显著或持续增高、超声与MSCT检查阴性或可疑人群中应用DSA检出早期肝癌的研究。方法:对肝癌高危人群中AFP显著或持续增高、超声或/和MSCT检查未发现明确病变或疑似肝癌的68例患者,行DSA造影。结果:68例患者中超声、MSCT检查阴性29例,疑似小肝癌者39例,DSA检出51例58个病灶。DSA表现为肝动脉早至中期供瘤血管增粗、走形迂曲或紊乱,边缘见较清楚的染色结节。17例DSA阴性或可疑病人在肝动脉内注射碘油约3-5ml,1月后复查CT,7例有碘油小灶沉积者手术治疗证实为肝癌,10例排除肝癌。结论:对高危人群中AFP显著增高和持续增高、超声与MSCT阴性或可疑人群应用DSA检出早期肝癌具有临床意义。 Objective: To apply subtraction angiography( DSA) to detect early hepatocellular carcinoma in the alpha- fetoprotein( AFP)- positive,ultrasound and / or multislice computed tomography( MSCT)- negative and suspicious population. Methods: All 68 cases consecutive patients that AFP was significantly or continuously increasing,and ultrasound and / or MSCT examination showed no definite or suspected HCC lesions in the high- risk population of hepatocellular carcinoma,were underwent DSA. Results: In 68 cases,29 were ultrasound and MSCT examination negative,39 cases were suspected of small hepatocellular carcinoma,DSA detected 58 lesions in 51 cases. DSA manifested hepatic artery early to middle period supplying tumor vascular thickening,tortous or wild disorder,with clear staining nodules in the edge. 17 cases of DSA negative and suspicious patients were injected about 3- 5ml lipiodol in the hepatic arterial,reviewing CT after one month,7 cases had lipiodol deposition or were confirmed of small hepatocellular carcinoma by operation,and 10 cases were excluded hepatocellular carcinoma. Conclusion: DSA detection for early hepatocellular carcinoma has clinical significance in the high- risk population with AFP significantly and continuously increasing,and ultrasound and / or MSCT negative or suspicious population.
出处 《现代肿瘤医学》 CAS 2014年第12期2924-2926,共3页 Journal of Modern Oncology
基金 湖北省荆州市重点科学技术资助项目(编号:2012CC48)
关键词 肝癌 AFP 超声 MSCT DSA hepatocellular carcinoma AFP ultrasound MSCT DSA
  • 相关文献

参考文献12

  • 1Grazi GL,Cescon M,Ravaioli M,et al.Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics:evaluation of clinico-pathologic features and comparison of risk factors for long-terra survival and tumor recurrence in a single center[J].Aliment Pharmacol Ther,2011,17:119.
  • 2Katyal S,Oliver JH,Peterson N,et al.Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepaocellular carcinoma[J].A JR,2009,175:1665-1672.
  • 3Livraghi T,Goldberg SN,Lazzaroni S,et al.Hepatocellular carcinoma:radicrlrequency ablation of medium and large lesions[J].Radiology,2010,214(3):761-768.
  • 4S Schacherer D,Schoelmerich J,Jerger I.The diagnostic approach to hepatocellular carcinoma Z Gastroeterol[J].Review German,2013,45(10):1067.
  • 5Rrieta O,Caeho B.The progressive elevation of a-fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis[J].BMC Cancer,2011,8 (7):28.
  • 6Nathalic G,Claude C,Francoise C,et al.Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasiain western patients with cirrhosis[J].Hepatology,1996,23:1112-1118.
  • 7Tsai JF,Jeng JE,Ho MS,et al.Effects of hepatitis Cand B virus infection on risk of hepatocellular carcinoma:a prospective study[J].Br J Cancer,2011,76:968-974.
  • 8Oliver JH,Baron RI.Helical biphasic contrast enhanced CT of the liver:technique,indications,interpretation,and pitfalls[J].Radiology,2012,201 (1):1-14.
  • 9Sato Y,Nakata K.Early recognition of hepatocellular carcinoma based on altered profiles of afetoprotein[J].N Engl J Med,2010,328 (25):1802-1806.
  • 10Bruix J,Sherman M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53 (3):1020-1022.

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部